Bretylium tosilate 100mg/2ml solution for injection ampoules
previously Bretylium tosilate 100mg/2ml solution for infusion ampoules
- SNOMED code
4638211000001103- Named
- Active compound
- Bretylium
- Preferred name basis
- rINN - Recommended International Non-proprietary
previously
rINN - Recommended International Non-proprietary - Prescribable
- Invalid to prescribe in NHS primary care
- Non-availability
- Actual Products not Available
- Non-availability date
- Dose form
- Discrete
- Dose size and units
- 2 ml, ampoule
- Ingredients
- Bretylium tosilate
— 50 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous, solutioninjection.intravenous, solutioninjection.intramuscular
Solution for injection, IntramuscularIntravenous - Controlled drug
- No Controlled Drug Status
Products
Bretylate 100mg/2ml solution for injection ampoules (GlaxoSmithKline UK Ltd)
previously Bretylate 100mg/2ml solution for infusion ampoules
Bretylate 100mg/2ml solution for injection ampoules
- SNOMED code
4625211000001107- Named
- Supplier
- GlaxoSmithKline UK Ltd
- Licensed as
- None
- Availability restrictions
- Not available
- Licensed routes
- Intramuscular, Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Bretylate 100mg/2ml solution for injection ampoules (GlaxoSmithKline UK Ltd) 5 ampoule4625311000001104 ref. pack |
Discontinued
Legal category: POM | No Price Available | — |
| — |
Reference packs
Bretylium tosilate 100mg/2ml solution for injection ampoules 5 ampoule
- SNOMED code
4625111000001101- Quantity and unit
- 5 ampoule
- Packs